Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity-Reference-Cited by-同舟云学术

Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity

Published:2014-03-24 Issue: Volume:5 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Chretien Anne-Sophie,Le Roy Aude,Vey Norbert,Prebet Thomas,Blaise Didier,Fauriat Cyril,Olive Daniel

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference158 articles.

1. Innate or adaptive immunity? The example of natural killer cells;Vivier;Science,2011

2. Human natural killer cells: molecular mechanisms controlling NK cell activation and tumor cell lysis;Moretta;Immunol Lett,2005

3. Targeting natural killer cells and natural killer T cells in cancer;Vivier;Nat Rev Immunol,2012

4. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo;Fernandez;Nat Med,1999

5. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells;Pende;J Exp Med,1999

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human papillomavirus and Merkel cell polyomavirus in Korean patients with nonsmall cell lung cancer: Evaluation and genetic variability of the noncoding control region;Journal of Medical Virology;2024-08

2. Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy;Frontiers in Immunology;2023-11-24

3. Synergist for antitumor therapy: Astragalus polysaccharides acting on immune microenvironment;Discover Oncology;2023-09-24

4. Advancements in Bispecific Antibody Development and Research Trends;Microbiology and Biotechnology Letters;2023-08-30

5. Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T;Molecular Cancer;2023-02-07